Mast cell density in Merkel cell carcinoma and its correlation with prognostic features and MCPyV status: a pilot study.
MCPyV
Mast cells
Merkel cell carcinoma
Recurrency
Tryptase
Tumor microenvironment
Journal
Clinical and experimental medicine
ISSN: 1591-9528
Titre abrégé: Clin Exp Med
Pays: Italy
ID NLM: 100973405
Informations de publication
Date de publication:
05 Jul 2024
05 Jul 2024
Historique:
received:
10
04
2024
accepted:
29
04
2024
medline:
5
7
2024
pubmed:
5
7
2024
entrez:
5
7
2024
Statut:
epublish
Résumé
Merkel cell carcinoma (MCC) is a rare, highly aggressive, primitive neuroendocrine carcinoma of the skin, the origin of which is not yet fully understood. Numerous independent prognostic factors have been investigated in an attempt to understand which are the most important parameters to indicate in the histological diagnostic report of MCC. Of these, mast cells have only been studied in one paper before this one. We present a retrospective descriptive study of 13 cases of MCC, received at the Department of Pathology over a 20-year period (2003-2023 inclusive) on which we performed a study using whole-slide (WSI) morphometric analysis scanning platform Aperio Scanscope CS for the detection and spatial distribution of mast cells, using monoclonal anti-tryptase antibody and anti-CD34 monoclonal antibody to study the density of microvessels. In addition, we analyzed MCPyV status with the antibody for MCPyV large T-antigen (Clone CM2B4). We found statistically significant correlation between mast cell density and local recurrence/distant metastasis/death-of-disease (p = 0.008). To our knowledge, we firstly reported that MCPyV ( -) MCC shows higher mast cells density compared to MCPyV ( +) MCC, the latter well known to be less aggressive. Besides, the median vascular density did not show no significant correlation with recurrence/metastasis/death-of-disease, (p = 0.18). Despite the small sample size, this paper prompts future studies investigating the role of mast cell density in MCC.
Identifiants
pubmed: 38967728
doi: 10.1007/s10238-024-01366-4
pii: 10.1007/s10238-024-01366-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
151Informations de copyright
© 2024. The Author(s).
Références
Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105(1):107–10 (PMID: 5009611).
doi: 10.1001/archderm.1972.01620040075020
pubmed: 5009611
WHO Classification of Skin Tumours, edited by Elder E.D., Massi, D.; Scolyer, R.A.; Willemze, R. IARC, 2018, Lyon, pp. 48–50.
Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010;37(1):20–7. https://doi.org/10.1111/j.1600-0560.2009.01370.x . (Epub 2009 Jul 23 PMID: 19638070).
doi: 10.1111/j.1600-0560.2009.01370.x
pubmed: 19638070
Feng H, Shuda M, Chang Y, Moore PS, Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096–100. https://doi.org/10.1126/science.1152586 . Epub 2008. PMID: 18202256; PMCID: PMC2740911.
Zaggana E, Konstantinou MP, Krasagakis GH, de Bree E, Kalpakis K, Mavroudis D, Krasagakis K. Merkel cell carcinoma-update on diagnosis, management and future perspectives. Cancers (Basel). 2022;15(1):103. https://doi.org/10.3390/cancers15010103.PMID:36612102;PMCID:PMC9817518 .
doi: 10.3390/cancers15010103.PMID:36612102;PMCID:PMC9817518
pubmed: 36612102
Goh G, Walradt T, Markarov V, Blom A, Riaz N, Doumani R, Stafstrom K, Moshiri A, Yelistratova L, Levinsohn J, Chan TA, Nghiem P, Lifton RP, Choi J. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy. Oncotarget. 2016;7(3):3403–15. https://doi.org/10.18632/oncotarget.6494 . PMID: 26655088; PMCID: PMC48 23115.
Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Peñas PF, Nghiem P. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008;58(3):375–81. https://doi.org/10.1016/j.jaad.2007.11.020.PMID:18280333;PMCID:PMC2335370 .
doi: 10.1016/j.jaad.2007.11.020.PMID:18280333;PMCID:PMC2335370
pubmed: 18280333
pmcid: 2335370
Ríos-Viñuela E, Mayo-Martínez F, Nagore E, Millan-Esteban D, Requena C, Sanmartín O, Llombart B. Combined Merkel cell carcinoma and squamous cell carcinoma: a systematic review. Cancers. 2024;16:411. https://doi.org/10.3390/cancers16020411 .
doi: 10.3390/cancers16020411
pubmed: 38254900
pmcid: 10814983
García-Mesa Y, Martín-Sanz R, García-Piqueras J, Cobo R, Muñoz-Bravo S, García-Suárez O, Martín-Biedma B, Vega JA, Feito J. Merkel cell carcinoma display PIEZO2 immunoreactivity. J Pers Med. 2022;12(6):894. https://doi.org/10.3390/jpm12060894.PMID:35743679;PMCID:PMC9224776 .
doi: 10.3390/jpm12060894.PMID:35743679;PMCID:PMC9224776
pubmed: 35743679
pmcid: 9224776
Pasternak S, Carter MD, Ly TY, Doucette S, Walsh NM. Immunohistochemical profiles of different subsets of Merkel cell carcinoma. Hum Pathol. 2018;82:232–8. https://doi.org/10.1016/j.humpath.2018.07.022 . (Epub 2018 Jul 29 PMID: 30067951).
doi: 10.1016/j.humpath.2018.07.022
pubmed: 30067951
Panse G, McNiff JM, Ko CJ. Basal cell carcinoma: CD56 and cytokeratin 5/6 staining patterns in the differential diagnosis with Merkel cell carcinoma. J Cutan Pathol. 2017;44(6):553–6. https://doi.org/10.1111/cup.12950 . (PMID: 28403527).
doi: 10.1111/cup.12950
pubmed: 28403527
McEvoy AM, Lachance K, Hippe DS, Cahill K, Moshiri Y, Lewis CW, Singh N, Park SY, Thuesmunn Z, Cook MM, Alexander NA, Zawacki L, Thomas H, Paulson KG, Nghiem P. Recurrence and mortality risk of Merkel cell carcinoma by cancer stage and time from diagnosis. JAMA Dermatol. 2022;158(4):382–9. https://doi.org/10.1001/jamadermatol.2021.6096.PMID:35195657;PMCID:PMC8867389 .
doi: 10.1001/jamadermatol.2021.6096.PMID:35195657;PMCID:PMC8867389
pubmed: 35195657
pmcid: 8867389
Lewis CW, Qazi J, Hippe DS, Lachance K, Thomas H, Cook MM, Juhlin I, Singh N, Thuesmunn Z, Takagishi SR, McEvoy A, Doolittle-Amieva C, Bhatia S, Paulson KG, O'Malley RB, Wang CL, Nghiem P. Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance. Cancer Med. 2020;9(4):1374–1382. https://doi.org/10.1002/cam4.2781 . Epub 2019 Dec 27. PMID: 31883234; PMCID: PMC7013053.
Ribatti D. Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis. Immunol Lett. 2013;152(2):83–8. https://doi.org/10.1016/j.imlet.2013.05.003 . (Epub 2013 May 15 PMID: 23685256).
doi: 10.1016/j.imlet.2013.05.003
pubmed: 23685256
Ribatti D, Crivellato E. The controversial role of mast cells in tumor growth. Int Rev Cell Mol Biol. 2009;275:89–131. https://doi.org/10.1016/S1937-6448(09)75004-X .
doi: 10.1016/S1937-6448(09)75004-X
pubmed: 19491054
de Souza JDA, Toso VD, Campos MR, et al. Expression of mast cell proteases correlates with mast cell maturation and angiogenesis during tumor progression. PLoS ONE. 2012;7: e40790. https://doi.org/10.1371/journal.pone.0040790 .
doi: 10.1371/journal.pone.0040790
pubmed: 22815822
pmcid: 3399855
Ricci C, Righi A, Ambrosi F, Gibertoni D, Maletta F, Uccella S, Sessa F, Asioli S, Pellilli M, Maragliano R, La Rosa S, Papotti MG, Asioli S. Prognostic impact of MCPyV and TIL subtyping in Merkel cell carcinoma: evidence from a large European Cohort of 95 Patients. Endocr Pathol. 2020;31(1):21–32. https://doi.org/10.1007/s12022-019-09601-5 . (PMID: 31808008).
doi: 10.1007/s12022-019-09601-5
pubmed: 31808008
Ryu H, Bi TM, Pulliam TH, Sarkar K, Church CD, Kumar N, Mayer-Blackwell K, Jani S, Ramchurren N, Hansen UK, Hadrup SR, Fling SP, Koelle DM, Nghiem P, Newell EW. Merkel cell polyomavirus-specific and CD39+CLA+ CD8 T cells as blood-based predictive biomarkers for PD-1 blockade in Merkel cell carcinoma. Cell Rep Med. 2024;5(2):101390. https://doi.org/10.1016/j.xcrm.2023.101390 . Epub 2024 Feb 9. PMID: 38340724; PMCID: PMC10897544.
Samimi M, Benlalam H, Aumond P, Gaboriaud P, Fradin D, Kervarrec T, Florenceau L, Vignard V, Blom A, Touzé A, Gervois N, Labarriere N. Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma. Cell Immunol. 2019;344: 103961. https://doi.org/10.1016/j.cellimm.2019.103961 . (Epub 2019 Aug 1 PMID: 31472938).
doi: 10.1016/j.cellimm.2019.103961
pubmed: 31472938
Beer TW, Ng LB, Murray K. Mast cells have prognostic value in Merkel cell carcinoma. Am J Dermatopathol. 2008;30(1):27–30. https://doi.org/10.1097/DAD.0b013e31815c932a . (PMID: 18212540).
doi: 10.1097/DAD.0b013e31815c932a
pubmed: 18212540
Soult MC, Feliberti EC, Silverberg ML, Perry RR. Merkel cell carcinoma: high recurrence rate despite aggressive treatment. J Surg Res. 2012;177(1):75–80. https://doi.org/10.1016/j.jss.2012.03.067 . (Epub 2012 Apr 16 PMID: 22537840).
doi: 10.1016/j.jss.2012.03.067
pubmed: 22537840
Sergi MC, Lauricella E, Porta C, Tucci M, Cives M. An update on Merkel cell carcinoma. Biochim Biophys Acta Rev Cancer. 2023;1878(3):188880. https://doi.org/10.1016/j.bbcan.2023.188880 . Epub 2023 Mar 11. PMID: 36914034.
Miner AG, Patel RM, Wilson DA, Procop GW, Minca EC, Fullen DR, Harms PW, Billings SD. Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus. Mod Pathol. 2015;28(4):498–504. https://doi.org/10.1038/modpathol.2014.148 . (Epub 2014 Nov 14 PMID: 25394777).
doi: 10.1038/modpathol.2014.148
pubmed: 25394777
Ch’ng S, Wallis RA, Yuan L, Davis PF, Tan ST. Mast cells and cutaneous malignancies. Mod Pathol. 2006;19(1):149–59. https://doi.org/10.1038/modpathol.3800474 . (PMID: 16258517).
doi: 10.1038/modpathol.3800474
pubmed: 16258517
Tóth-Jakatics R, Jimi S, Takebayashi S, Kawamoto N. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. Hum Pathol. 2000;31(8):955–60. https://doi.org/10.1053/hupa.2000.16658 . (PMID: 10987256).
doi: 10.1053/hupa.2000.16658
pubmed: 10987256
Ribatti D, Ennas MG, Vacca A, Ferreli F, Nico B, Orru S, Sirigu P. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest. 2003;33(5):420–5. https://doi.org/10.1046/j.1365-2362.2003.01152.x . (PMID: 12760367).
doi: 10.1046/j.1365-2362.2003.01152.x
pubmed: 12760367
Rajabi P, Bagheri A, Hani M. Intratumoral and peritumoral mast cells in malignant melanoma: an immunohistochemical study. Adv Biomed Res. 2017;6:39. https://doi.org/10.4103/2277-9175.204592.PMID:28503494;PMCID:PMC5414406 .
doi: 10.4103/2277-9175.204592.PMID:28503494;PMCID:PMC5414406
pubmed: 28503494
pmcid: 5414406
https://documents.cap.org/protocols/Skin.Merkel_4.1.0.0.REL_CAPCP.docx . Cap website.
Skelton HG, Smith KJ, Hitchcock CL, McCarthy WF, Lupton GP, Graham JH. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol. 1997;37(5 Pt 1):734–9. https://doi.org/10.1016/s0190-9622(97)70110-5 . (PMID: 9366819).
doi: 10.1016/s0190-9622(97)70110-5
pubmed: 9366819
Smith PD, Patterson JW. Merkel cell carcinoma (neuroendocrine carcinoma of the skin). Am J Clin Pathol. 2001;115(Suppl):S68-78. https://doi.org/10.1309/MVXR-8BM1-GPR7-P5NP . (PMID: 11993692).
doi: 10.1309/MVXR-8BM1-GPR7-P5NP
pubmed: 11993692
Koljonen V, Böhling T, Granhroth G, Tukiainen E. Merkel cell carcinoma: a clinicopathological study of 34 patients. Eur J Surg Oncol. 2003;29(7):607–10. https://doi.org/10.1016/s0748-7983(03)00110-0 . (PMID: 12943628).
doi: 10.1016/s0748-7983(03)00110-0
pubmed: 12943628
Sandel HD, Day T, Richardson MS, Scarlett M, Gutman KA. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival? Laryngoscope. 2006;116(5):791–5. https://doi.org/10.1097/01.mlg.0000208615.93883.b2 . PMID: 16652089.
Pitale M, Sessions RB, Husain S. An analysis of prognostic factors in cutaneous neuroendocrine carcinoma. Laryngoscope. 1992;102(3):244–9. https://doi.org/10.1288/00005537-199203000-00003 . (PMID: 1545650).
doi: 10.1288/00005537-199203000-00003
pubmed: 1545650
Gillenwater AM, Hessel AC, Morrison WH, Burgess M, Silva EG, Roberts D, Goepfert H. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg. 2001;127(2):149–54. https://doi.org/10.1001/archotol.127.2.149 . (PMID: 11177031).
doi: 10.1001/archotol.127.2.149
pubmed: 11177031
Ribatti D, Tamma R, Annese T, Crivellato E. The role of mast cells in human skin cancers. Clin Exp Med. 2021;21(3):355–60. https://doi.org/10.1007/s10238-021-00688-x . (Epub 2021 Feb 12 PMID: 33576908).
doi: 10.1007/s10238-021-00688-x
pubmed: 33576908
Ribatti D, Vacca A, Ria R, Marzullo A, Nico B, Filotico R, Roncali L, Dammacco F. Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer. 2003;39(5):666–74. https://doi.org/10.1016/s0959-8049(02)00150-8 . (PMID: 12628847).
doi: 10.1016/s0959-8049(02)00150-8
pubmed: 12628847
Schadendorf D, Lebbé C, Zur Hausen A, et al. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs. Eur J Cancer. 2017;71:53–69. https://doi.org/10.1016/j.ejca.2016.10.022 .
doi: 10.1016/j.ejca.2016.10.022
pubmed: 27984768
Paulson KG, Lemos BD, Feng B, et al. Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. J Invest Dermatol. 2009;129(6):1547–55. https://doi.org/10.1038/jid.2008.365 .
doi: 10.1038/jid.2008.365
pubmed: 19020549
Harms PW, Vats P, Verhaegen ME, et al. The distinctive mutational spectra of polyomavirus-negative Merkel Cell carcinoma. Cancer Res. 2015;75(18):3720–7. https://doi.org/10.1158/0008-5472.CAN-15-0702 .
doi: 10.1158/0008-5472.CAN-15-0702
pubmed: 26238782
pmcid: 4573907
Nardi V, Song Y, Santamaria-Barria JA, et al. Activation of PI3K signaling in Merkel cell carcinoma. Clin Cancer Res. 2012;18(5):1227–36. https://doi.org/10.1158/1078-0432.CCR-11-2308 .
doi: 10.1158/1078-0432.CCR-11-2308
pubmed: 22261808
pmcid: 3912509
Moshiri AS, Doumani R, Yelistratova L, et al. Polyomavirus-negative Merkel cell carcinoma: a more aggressive subtype based on analysis of 282 cases using multimodal tumor virus detection. J Invest Dermatol. 2017;137(4):819–27. https://doi.org/10.1016/j.jid.2016.10.028 .
doi: 10.1016/j.jid.2016.10.028
pubmed: 27815175
Calonje E, Brenn T, Lazar A, & McKee PH. 2012. McKee's pathology of the skin: with clinical correlations. (4th ed. ed.) Elsevier/Saunders.